v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (4,058,528) $ (4,856,831)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation 532,982 1,179,347
Amortization 20,638 19,754
Accretion of discount on note payable 111,656
Decrease in assets    
Prepaid expenses 23,400
Increase in liabilities    
Accounts payable and accrued expenses 1,110,426 553,894
Accounts payable and accrued expenses - related parties (2,269) (1,981)
Net cash used in operating activities (2,261,695) (3,105,817)
CASH FLOWS FROM INVESTING ACTIVITIES    
Investment in patents (3,585)
Net cash used in investing activities (3,585)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from notes payable - other 1,273,022
Proceeds from sale of 10% secured convertible notes payable - stockholders 925,000 2,000,000
Net cash provided by financing activities 2,198,022 2,000,000
DECREASE IN CASH AND CASH EQUIVALENTS (63,673) (1,109,402)
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD 158,687 3,011,493
CASH AND CASH EQUIVALENTS - END OF PERIOD 95,014 1,902,091
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Interest
Income taxes
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:    
Accrued preferred dividends 1,374,721 1,409,198
Fair value of options issued as a discount for notes payable $ 86,457